Global Neuroscience Antibodies and Assays Market 2024-2028

Global Neuroscience Antibodies And Assays Market 2024-2028

The neuroscience antibodies and assays market is forecasted to grow by USD 2.20 bn during 2023-2028, accelerating at a CAGR of 9.64% during the forecast period. The report on the neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidences of neurological disorders, increasing initiatives and support from governments and healthcare organizations, and technological advances in antibody manufacturing.

Technavio's neuroscience antibodies and assays market is segmented as below:

By Type

• Consumables
• Instruments

By Application

• Pharmaceutical and biopharmaceutical companies
• Academic and research institutes
• Hospital and diagnostic centers

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing clinical trials as one of the prime reasons driving the neuroscience antibodies and assays market growth during the next few years. Also, emergence of liquid biopsies and rising adoption of single-cell analysis techniques will lead to sizable demand in the market.

The report on the neuroscience antibodies and assays market covers the following areas:

• Neuroscience antibodies and assays market sizing
• Neuroscience antibodies and assays market forecast
• Neuroscience antibodies and assays market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuroscience antibodies and assays market vendors that include Abcam plc, Abnova Corp., Bio Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., GenScript Biotech Corp., Kaneka Corp., Merck KGaA, NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., and Thermo Fisher Scientific Inc.. Also, the neuroscience antibodies and assays market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.